Announced Wed, 8 Jul · 14:50 IST
Quarterly compliance certificate for dematerialisation filed with BSE
Compliance View source PDF
AAREYDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Price reaction · full curve 14 horizons · vs prior close
-3.9%1-day move
₹87.99
prior close
—
base price
In-mkt
timing
5m10m15m30m1D2D3D4D5D7D15D1M2M3M
————-3.9-5.9-7.7-9.6-11.4-14.9————
Up moveDown movePending
AI summary
Aarey Drugs & Pharmaceuticals submitted a compliance certificate under SEBI Regulation 74(5) for the quarter ended 30 June 2026. MUFG Intime India, the company's registrar and share transfer agent, confirmed that securities received from depository participants for dematerialisation during the quarter were processed, certificates were mutilated and cancelled after verification, and the depositories' names were substituted in the register of members within the prescribed timelines.
Likely market impact
Routine regulatory compliance filing. No material impact on shareholders or stock price.